As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines could be due for a shake up with new healthcare leaders set to take charge in the US.

Conduit Pharmaceuticals has signed an agreement with Sarborg to leverage advanced AI and cybernetics for the optimisation of processes related to key drug development. These include the repurposing ...

AIM ImmunoTech has secured a patent from the Netherlands Patent Office for Ampligen, targeting the treatment of post-Covid fatigue.

Olomorasib is a small molecule commercialized by Eli Lilly and Co, with a leading Phase III program in Non-Small Cell Lung Cancer.

Ponsegromab is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Cancer Anorexia-Cachexia Syndrome.

A successful clinical trial requires an effective randomization strategy formulated by innovative thinking to meet unique demands. In a recent webinar, Solventum revealed how the eClinical platform ...

Zelicapavir is a small molecule commercialized by Enanta Pharmaceuticals, with a leading Phase II program in Respiratory Syncytial Virus (RSV) Infections.

Lepodisiran sodium is an antisense rnai oligonucleotide commercialized by Eli Lilly and Co, with a leading Phase III program in Atherosclerosis.

Reolysin is an oncolytic virus commercialized by Oncolytics Biotech, with a leading Phase II program in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer).

Empasiprubart is a monoclonal antibody commercialized by Argenx, with a leading Phase II program in Multifocal Motor Neuropathy.

The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several events.